|
KIAA0146 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.400800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.976400E-02 |
| Normal-vs-Stage2 |
9.355200E-01 |
| Normal-vs-Stage3 |
5.739400E-01 |
| Normal-vs-Stage4 |
6.617600E-01 |
| Stage1-vs-Stage2 |
1.032990E-01 |
| Stage1-vs-Stage3 |
1.904250E-01 |
| Stage1-vs-Stage4 |
2.827600E-01 |
| Stage2-vs-Stage3 |
6.601400E-01 |
| Stage2-vs-Stage4 |
7.300200E-01 |
| Stage3-vs-Stage4 |
9.518600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.086200E-01 |
| Normal-vs-AfricanAmerican |
2.215600E-01 |
| Normal-vs-Asian |
4.837000E-01 |
| Caucasian-vs-AfricanAmerican |
5.216600E-01 |
| Caucasian-vs-Asian |
7.262200E-01 |
| AfricanAmerican-vs-Asian |
9.344800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.188000E-01 |
| Normal-vs-Female |
6.776000E-02 |
| Male-vs-Female |
3.915800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.279600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.193400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.452600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.900200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.884400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.170200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.698000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.362200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.377800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.679800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.101360E-03 |
| Normal-vs-Grade 2 |
3.423500E-02 |
| Normal-vs-Grade 3 |
6.300600E-01 |
| Normal-vs-Grade 4 |
3.752200E-01 |
| Grade 1-vs-Grade 2 |
1.787970E-02 |
| Grade 1-vs-Grade 3 |
4.182600E-03 |
| Grade 1-vs-Grade 4 |
1.363180E-04 |
| Grade 2-vs-Grade 3 |
3.216400E-02 |
| Grade 2-vs-Grade 4 |
1.164500E-03 |
| Grade 3-vs-Grade 4 |
1.372970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.236200E-02 |
| Normal-vs-ccB subtype |
7.733400E-01 |
| ccA subtype-vs-ccB subtype |
7.610300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.619600E-01 |
| Normal-vs-N1 |
4.639200E-01 |
| N0-vs-N1 |
2.369800E-01 |
|
|
